Antipsychotics in pregnancy and lactation

Area of Science:

• Perinatal Psychiatry
• Psychopharmacology
• Reproductive Toxicology

Background:

• Limited research exists on psychotropic medication use during pregnancy and lactation due to ethical complexities.
• Safety data for many psychotropic drugs in pregnant and lactating women is inconclusive or undetermined.
• Women with severe mental illness often experience unplanned pregnancies, necessitating medication during these critical periods.

Purpose of the Study:

• To highlight the challenges and considerations in managing psychotropic medication for pregnant and lactating women.
• To emphasize the need for individualized treatment strategies based on safety and patient history.
• To outline essential components of comprehensive care, including pre-pregnancy counseling and interdisciplinary collaboration.

Main Methods:

• Review of existing literature and clinical considerations for psychotropic drug use in pregnancy and lactation.
• Emphasis on individualized treatment planning.
• Integration of non-pharmacological approaches where feasible.

Main Results:

• Choosing safe psychotropic treatments requires careful consideration of multiple factors.
• Treatment decisions should prioritize drug safety data and the patient's psychiatric history.
• Comprehensive management involves pre-pregnancy counseling, folate supplementation, patient-family discussions, and multidisciplinary team collaboration.

Conclusions:

• Individualized treatment is paramount for pregnant and lactating women requiring psychotropic medication.
• A collaborative approach involving obstetricians, pediatricians, and other specialists is essential.
• Non-pharmacological interventions should be considered as adjuncts to medication.